GFR Estimating Equations in a Multiethnic Asian Population

被引:245
作者
Teo, Boon Wee [1 ]
Xu, Hui [1 ]
Wang, Danhua [1 ,2 ]
Li, Jialiang [2 ]
Sinha, Arvind Kumar [3 ]
Shuter, Borys [4 ]
Sethi, Sunil [5 ]
Lee, Evan J. C. [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Div Nephrol, Singapore 119228, Singapore
[2] Natl Univ Singapore, Fac Sci, Dept Stat & Appl Probabil, Singapore 119228, Singapore
[3] Natl Univ Singapore Hosp, Dept Diagnost Imaging, Singapore, Singapore
[4] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Radiol, Singapore 119228, Singapore
[5] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 119228, Singapore
基金
英国医学研究理事会;
关键词
Glomerular filtration rate; ethnic groups; Asians; chronic kidney failure; creatinine; bias; GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; CHINESE PATIENTS; PREDICTION; CLEARANCE; DISEASE;
D O I
10.1053/j.ajkd.2011.02.393
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Clinical practice guidelines recommend using equations for estimating glomerular filtration rate (GFR) in chronic kidney disease (CKD) management and research. The MDRD (Modification of Diet in Renal Disease) Study and CKD-EPI (CKD Epidemiology Collaboration) equations originally were derived from a North American population and had an ethnic coefficient adjustment for African Americans. A Chinese coefficient for the MDRD Study equation subsequently was determined, but this has not been externally validated. We compared the accuracy of the equations, evaluated the ethnic coefficients, and assessed the equations for disease staging in a multiethnic Asian population with CKD. Study Design: A diagnostic test study comparing the Asian coefficient (and subgroups)-modified MDRD Study and CKD-EPI equations and a cross-sectional study assessing disease staging. Setting & Participants: 232 outpatients (52% men; 40.5% Chinese, 32% Malay, and 27.5% Indian/other) with stable CKD. Index Test: Asian and ethnicity-based modifications of the MDRD Study and CKD-EPI equations. Reference Test: Measured GFR using 3-sample plasma clearance of technetium-99m diethylenetriaminepentaacetic acid (Tc-99m-DTPA), calculated using the slope-intercept method, with body surface area normalization (du Bois) and Brochner-Mortensen correction. Results: Overall, the CKD-EPI equation is more accurate than the MDRD Study equation throughout the GFR range, with improved bias (median difference of estimated GFR - measured GFR) and root mean square error (P < 0.001). CKD-EPI versus MDRD Study equation: bias, 1.1 +/- 13.8 vs -1.0 +/- 15.2 mL/min/1.73 m(2); precision, 12.1 vs 12.2 mL/min/1.73 m(2). Ethnic coefficients did not improve estimates of GFR significantly. The correctness of staging was improved using the CKD-EPI equation. Limitations: All participants had CKD, but few were of European descent. The reference GFR technique was different from the original studies. Conclusions: The CKD-EPI is more accurate than the MDRD Study equation, particularly at higher GFRs. Therefore, we recommend adopting the CKD-EPI equation without ethnic adjustment for estimating GFR in multiethnic Asian patients with CKD. Am J Kidney Dis. 58(1):56-63. (C) 2011 by the National Kidney Foundation, Inc.
引用
收藏
页码:56 / 63
页数:8
相关论文
共 19 条
[1]  
Blaufox MD, 1996, J NUCL MED, V37, P1883
[3]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[4]  
Du Bois D, 1989, Nutrition, V5, P303
[5]  
DUBOIS D, 1989, NUTRITION, V5, P303
[6]   Power and sample size calculations for studies involving linear regression [J].
Dupont, WD ;
Plummer, WD .
CONTROLLED CLINICAL TRIALS, 1998, 19 (06) :589-601
[7]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[8]   Guidelines for the measurement of glomerular filtration rate using plasma sampling [J].
Fleming, JS ;
Zivanovic, MA ;
Blake, GM ;
Burniston, M ;
Cosgriff, PS .
NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (08) :759-769
[9]  
GOATES JJ, 1990, J NUCL MED, V31, P424
[10]  
KLOPPER JF, 1972, J NUCL MED, V13, P107